USD
+$0.00
(+0.00%
)At Close (As of Sep 9, 2025)
$48.87M
Market Cap
-
P/E Ratio
-2.96
EPS
$10.05
52 Week High
$0.88
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$1.5M |
Total Revenue | $0 |
Cost Of Revenue | $1.5M |
Costof Goods And Services Sold | $1.5M |
Operating Income | -$98M |
Selling General And Administrative | $21M |
Research And Development | $76M |
Operating Expenses | $96M |
Investment Income Net | - |
Net Interest Income | $7.1M |
Interest Income | $7.1M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.5M |
Income Before Tax | -$91M |
Income Tax Expense | -$617K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$90M |
Comprehensive Income Net Of Tax | - |
Ebit | -$91M |
Ebitda | -$89M |
Net Income | -$90M |
Field | Value (USD) |
---|---|
Total Assets | $151M |
Total Current Assets | $124M |
Cash And Cash Equivalents At Carrying Value | $49M |
Cash And Short Term Investments | $49M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $27M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $71M |
Other Current Assets | $3.6M |
Other Non Current Assets | - |
Total Liabilities | $32M |
Total Current Liabilities | $17M |
Current Accounts Payable | $1.8M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $6.2M |
Total Non Current Liabilities | $16M |
Capital Lease Obligations | $19M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $19M |
Other Current Liabilities | $8.8M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $119M |
Treasury Stock | - |
Retained Earnings | -$271M |
Common Stock | $3K |
Common Stock Shares Outstanding | $32M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$82M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $5.3M |
Capital Expenditures | $497K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$38M |
Cashflow From Financing | $89M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$90M |
Field | Value (USD) |
---|---|
Gross Profit | -$1.5M |
Total Revenue | $0 |
Cost Of Revenue | $1.5M |
Costof Goods And Services Sold | $1.5M |
Operating Income | -$98M |
Selling General And Administrative | $21M |
Research And Development | $76M |
Operating Expenses | $96M |
Investment Income Net | - |
Net Interest Income | $7.1M |
Interest Income | $7.1M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.5M |
Income Before Tax | -$91M |
Income Tax Expense | -$617K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$90M |
Comprehensive Income Net Of Tax | - |
Ebit | -$91M |
Ebitda | -$89M |
Net Income | -$90M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious neurological and neuromuscular diseases. The company is headquartered in Cambridge, Massachusetts.